{"entity":{"type":"insider","cik":"0001403322","url":"/insider/0001403322","json_url":"/insider/0001403322.json","name":"Malley Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":11,"first":"2007-07-20","last":"2025-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Malley Thomas","source":"filing","n_filings":11,"first_seen":"2007-07-20","last_seen":"2025-08-14"}],"transactions":[{"id":4953188,"accession":"0001415889-25-021941","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001415889-25-021941","line_url":"/filing/0001415889-25-021941#line-10","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78233.0,"shares_display":"78,233","price_per_share":33.09,"price_display":"33.09","price_state":"stated","total_value":2588729.97,"total_display":"2,588,729.97","total_whole":"2,588,730","shares_owned_after":12546.0,"shares_owned_after_display":"12,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-14","scope":"insider"},{"id":4953174,"accession":"0001415889-25-021941","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-021941","line_url":"/filing/0001415889-25-021941#line-6","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50129.0,"shares_display":"50,129","price_per_share":33.32,"price_display":"33.32","price_state":"stated","total_value":1670298.28,"total_display":"1,670,298.28","total_whole":"1,670,298","shares_owned_after":12546.0,"shares_owned_after_display":"12,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider"},{"id":4953162,"accession":"0001415889-25-021941","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-021941","line_url":"/filing/0001415889-25-021941#line-3","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49407.0,"shares_display":"49,407","price_per_share":32.4,"price_display":"32.40","price_state":"stated","total_value":1600786.8,"total_display":"1,600,786.80","total_whole":"1,600,787","shares_owned_after":12546.0,"shares_owned_after_display":"12,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":7998618,"accession":"0001209191-23-038797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038797","line_url":"/filing/0001209191-23-038797#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":575000.0,"total_display":"575,000.00","total_whole":"575,000","shares_owned_after":139557.0,"shares_owned_after_display":"139,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider"},{"id":2694042,"accession":"0001179110-16-032122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-032122","line_url":"/filing/0001179110-16-032122#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":960000.0,"total_display":"960,000.00","total_whole":"960,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-11-28","scope":"insider"},{"id":8420669,"accession":"0001209191-15-085761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-085761","line_url":"/filing/0001209191-15-085761#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":89557.0,"shares_owned_after_display":"89,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-12-17","scope":"insider"},{"id":8843963,"accession":"0001179110-15-006166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-006166","line_url":"/filing/0001179110-15-006166#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVAS","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":28.5,"price_display":"28.50","price_state":"stated","total_value":142500.0,"total_display":"142,500.00","total_whole":"142,500","shares_owned_after":122200.0,"shares_owned_after_display":"122,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-08","filed_date":"2015-04-09","scope":"insider"},{"id":8714583,"accession":"0001179110-15-000927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-000927","line_url":"/filing/0001179110-15-000927#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVAS","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":1750000.0,"total_display":"1,750,000.00","total_whole":"1,750,000","shares_owned_after":116819.0,"shares_owned_after_display":"116,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-13","filed_date":"2015-01-15","scope":"insider"},{"id":4622479,"accession":"0001179110-13-005558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-005558","line_url":"/filing/0001179110-13-005558#line-1","is_derivative":false,"issuer_cik":"0001403322","issuer_name":"OvaScience, Inc.","issuer_ticker":"OVSC","issuer_name_source":null,"issuer_url":"/issuer/0001403322","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":81819.0,"shares_owned_after_display":"81,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-20","scope":"insider"},{"id":3516971,"accession":"0001181431-12-055555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-055555","line_url":"/filing/0001181431-12-055555#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":156551.0,"shares_owned_after_display":"156,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-24","filed_date":"2012-10-25","scope":"insider"},{"id":3303507,"accession":"0001181431-12-036204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-036204","line_url":"/filing/0001181431-12-036204#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10032.0,"shares_display":"10,032","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":125400.0,"total_display":"125,400.00","total_whole":"125,400","shares_owned_after":146551.0,"shares_owned_after_display":"146,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-11","filed_date":"2012-06-13","scope":"insider"},{"id":3460153,"accession":"0001181431-12-035716","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-035716","line_url":"/filing/0001181431-12-035716#line-2","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8168.0,"shares_display":"8,168","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":102100.0,"total_display":"102,100.00","total_whole":"102,100","shares_owned_after":136519.0,"shares_owned_after_display":"136,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-08","filed_date":"2012-06-11","scope":"insider"},{"id":3460150,"accession":"0001181431-12-035716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-035716","line_url":"/filing/0001181431-12-035716#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":128351.0,"shares_owned_after_display":"128,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-07","filed_date":"2012-06-11","scope":"insider"},{"id":8375551,"accession":"0001179110-07-015147","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-07-015147","line_url":"/filing/0001179110-07-015147#line-3","is_derivative":false,"issuer_cik":"0001335102","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001335102","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8068.0,"shares_display":"8,068","price_per_share":21.75,"price_display":"21.75","price_state":"stated","total_value":175479.0,"total_display":"175,479.00","total_whole":"175,479","shares_owned_after":19918.0,"shares_owned_after_display":"19,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-19","filed_date":"2007-07-20","scope":"insider"},{"id":8375547,"accession":"0001179110-07-015147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-015147","line_url":"/filing/0001179110-07-015147#line-2","is_derivative":false,"issuer_cik":"0001335102","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001335102","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":21.75,"price_display":"21.75","price_state":"stated","total_value":184875.0,"total_display":"184,875.00","total_whole":"184,875","shares_owned_after":11850.0,"shares_owned_after_display":"11,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-18","filed_date":"2007-07-20","scope":"insider"},{"id":8375541,"accession":"0001179110-07-015147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-015147","line_url":"/filing/0001179110-07-015147#line-1","is_derivative":false,"issuer_cik":"0001335102","issuer_name":"Cougar Biotechnology, Inc.","issuer_ticker":"CGRB","issuer_name_source":null,"issuer_url":"/issuer/0001335102","owner_cik":"0001403322","owner_name":"Malley Thomas","owner_display_name":"Malley Thomas","owner_url":"/insider/0001403322","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3350.0,"shares_display":"3,350","price_per_share":21.75,"price_display":"21.75","price_state":"stated","total_value":72862.5,"total_display":"72,862.50","total_whole":"72,863","shares_owned_after":3350.0,"shares_owned_after_display":"3,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-17","filed_date":"2007-07-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Director","n_filings":1,"first_seen":"2025-08-14","last_seen":"2025-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Director","n_filings":2,"first_seen":"2015-12-17","last_seen":"2023-06-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001651308","name":"BeiGene, Ltd.","url":"/issuer/0001651308","role":"Director","n_filings":1,"first_seen":"2016-11-28","last_seen":"2016-11-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001544227","name":"OvaScience, Inc.","url":"/issuer/0001544227","role":"Director","n_filings":3,"first_seen":"2013-03-20","last_seen":"2015-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001401667","name":"PUMA BIOTECHNOLOGY, INC.","url":"/issuer/0001401667","role":"Director","n_filings":3,"first_seen":"2012-06-11","last_seen":"2012-10-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001335102","name":"Cougar Biotechnology, Inc.","url":"/issuer/0001335102","role":"Director","n_filings":1,"first_seen":"2007-07-20","last_seen":"2007-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001403322","retrieved_at":"2026-08-22T06:15:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}